StockData
Biomerica Inc logo

Biomerica Inc (BMRA) stock

BMRANasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 15, 2026Score 8/3049% below fair value
$1.09−0.15 (-11.74%)

Close on Nov 18, 2026Market cap $5.01MP/E –Yield –

Biomerica revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Biomerica's revenue for the twelve months ending Aug 31, 2026 was $4.34M, down 11.2% year over year. For fiscal 2026 it was $4.45M, down 16.2% from the year before. Over ten years it grew -1.4% a year on average. The highest annual figure on record is $18.87M in fiscal 2022.

Annual revenue

PeriodPeriod endValueChange
FY2026May 31, 2026$4.45M-16.2%
FY2025May 31, 2025$5.31M-1.9%
FY2024May 31, 2024$5.42M+1.4%
FY2023May 31, 2023$5.34M-71.7%
FY2022May 31, 2022$18.87M+162.1%
FY2021May 31, 2021$7.20M+7.6%
FY2020May 31, 2020$6.69M+28.7%
FY2019May 31, 2019$5.20M-6.5%
FY2018May 31, 2018$5.56M-3.9%
FY2017May 31, 2017$5.79M+12.7%
FY2016May 31, 2016$5.14M+3.6%
FY2015May 31, 2015$4.96M-3.1%
FY2014May 31, 2014$5.12M-20.9%
FY2013May 31, 2013$6.47M+6.4%
FY2012May 31, 2012$6.08M+24.1%
FY2011May 31, 2011$4.90M–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Aug 31, 2026$1.27M-8.3%
Q4 FY2026CQ2 2026May 31, 2026$875.00K+16.8%
Q3 FY2026CQ1 2026Feb 28, 2026$987.00K-11.8%
Q2 FY2026CQ4 2025Nov 30, 2025$1.21M-26.0%
Q1 FY2026CQ3 2025Aug 31, 2025$1.38M-23.6%
Q4 FY2025CQ2 2025May 31, 2025$749.00K-32.9%
Q3 FY2025CQ1 2025Feb 28, 2025$1.12M+10.0%
Q2 FY2025CQ4 2024Nov 30, 2024$1.64M+4.4%
Q1 FY2025CQ3 2024Aug 31, 2024$1.81M+5.5%
Q4 FY2024CQ2 2024May 31, 2024$1.12M+0.7%
Q3 FY2024CQ1 2024Feb 29, 2024$1.02M-8.5%
Q2 FY2024CQ4 2023Nov 30, 2023$1.57M+5.7%
Q1 FY2024CQ3 2023Aug 31, 2023$1.71M+4.6%
Q4 FY2023CQ2 2023May 31, 2023$1.11M-79.1%
Q3 FY2023CQ1 2023Feb 28, 2023$1.11M-85.5%
Q2 FY2023CQ4 2022Nov 30, 2022$1.48M-68.1%
Q1 FY2023CQ3 2022Aug 31, 2022$1.64M+29.7%
Q4 FY2022CQ2 2022May 31, 2022$5.30M+403.0%
Q3 FY2022CQ1 2022Feb 28, 2022$7.66M+111.1%
Q2 FY2022CQ4 2021Nov 30, 2021$4.65M+238.6%
Q1 FY2022CQ3 2021Aug 31, 2021$1.26M+10.3%
Q4 FY2021CQ2 2021May 31, 2021$1.05M-61.3%
Q3 FY2021CQ1 2021Feb 28, 2021$3.63M+208.3%
Q2 FY2021CQ4 2020Nov 30, 2020$1.37M-14.0%
Q1 FY2021CQ3 2020Aug 31, 2020$1.14M-4.2%
Q4 FY2020CQ2 2020May 31, 2020$2.72M+133.7%
Q3 FY2020CQ1 2020Feb 29, 2020$1.18M-6.7%
Q2 FY2020CQ4 2019Nov 30, 2019$1.60M+6.4%
Q1 FY2020CQ3 2019Aug 31, 2019$1.19M-6.2%
Q4 FY2019CQ2 2019May 31, 2019$1.17M+3.1%
Q3 FY2019CQ1 2019Feb 28, 2019$1.26M-8.3%
Q2 FY2019CQ4 2018Nov 30, 2018$1.50M-7.0%
Q1 FY2019CQ3 2018Aug 31, 2018$1.27M-11.9%
Q4 FY2018CQ2 2018May 31, 2018$1.13M-22.0%
Q3 FY2018CQ1 2018Feb 28, 2018$1.38M-8.3%
Q2 FY2018CQ4 2017Nov 30, 2017$1.61M+12.7%
Q1 FY2018CQ3 2017Aug 31, 2017$1.44M–
Q4 FY2017CQ2 2017May 31, 2017$1.45M–
Q3 FY2017CQ1 2017Feb 28, 2017$1.50M–
Q2 FY2017CQ4 2016Nov 30, 2016$1.43M–

More Biomerica figures

See a number that looks wrong?